Back
AbCellera Biologics 10K Form
Sell
35
ABCL
AbCellera Biologics
Last Price:
3.76
Seasonality Move:
-3.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-30 | 10K | ABCL/AbCellera Biologics Annual |
Receive ABCL News And Ratings
See the #1 stock for the next 7 days that we like better than ABCL
ABCL Financial Statistics
Sales & Book Value
| Annual Sales: | $38.03M |
|---|---|
| Cash Flow: | $-34.04M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.96 |
| Price / Book: | 0.96 |
Profitability
| EPS (TTM): | -0.52000 |
|---|---|
| Net Income (TTM): | $-146.4M |
| Gross Margin: | $38.03M |
| Return on Equity: | -12.26% |
| Return on Assets: | -9.66% |
AbCellera Biologics Earnings Forecast
Key AbCellera Biologics Financial Ratios
- The Gross Profit Margin over the past 6 years for ABCL is 100.00%.
- The Selling, General & Administrative Expenses for ABCL have been equal to 197.71% of Gross Profit Margin.
- The Research & Development expenses have been 461.95% of Revenue.
- The Interest Expense is 2.55% of Operating Income.
- The Net Earning history of ABCL is -385.00% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
AbCellera Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ABCL |
| CUSIP: | 00288U |
| Website: | abcellera.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.33 |
| Quick Ratio: | 6.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABCL Technical Analysis vs Fundamental Analysis
Sell
35
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy or a Sell?
-
AbCellera Biologics stock is rated a Sell
The current AbCellera Biologics [ABCL] share price is $3.76. The Score for ABCL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.